Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

Federated machine learning to take on brain-tumor diagnosis

The University of Pennsylvania is teaming with Intel to lead a federation of more than two dozen medical and research centers on an AI system for identifying brain tumors.

Thumbnail

Algorithmic model almost 80% accurate at diagnosing COVID in app users

Researchers in the U.K. and U.S. have developed an automatic prediction model that can tell if someone is infected with COVID-19 based on symptoms alone.

Thumbnail

Mayo Clinic partnering with UK tech company on COVID’s cardiac impact

The aim of the collaboration is to map out cardiac irregularities caused by the virus.

AI deftly reclassifies lung nodules for cancer risk

A convolutional neural network trained and internally validated on more than 15,000 lung CT scans has correctly reclassified indeterminate pulmonary nodules into low-risk or high-risk categories.

Thumbnail

FDA signs off on AI algorithms for detecting COVID-19 in incidental CT findings

The FDA has permitted the use of Aidoc’s AI models for the detection and prioritization of incidental CT findings associated with COVID-19.

Thumbnail

Many eyes on x-ray AI for COVID-19 detection

AI developers working to refine COVID-19 detection in chest x-rays must navigate two unavoidable speed bumps.

Thumbnail

AI researchers set sights on detecting COVID-19 in imaging results

Researchers are hard at work developing new AI algorithms that could help radiologists diagnose COVID-19 patients.

Thumbnail

Deep learning classifies Alzheimer’s for personalized diagnosis, risk prediction

An AI algorithm has slightly outperformed neurologists at identifying or ruling out Alzheimer’s disease from MRI brain scans combined with demographic information and neuropsychological test results.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup